48,536
edits
(16 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ Infobox diagnosis | {{ Infobox diagnosis | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Image = | | Image = Non-small cell lung carcinoma -- high mag.jpg | ||
| Width = | | Width = | ||
| Caption = | | Caption = Non-small cell lung carcinoma. [[H&E stain]]. | ||
| Synonyms = large cell carcinoma (term discouraged in the context of biopsies & FNAs) | | Synonyms = large cell carcinoma (term discouraged in the context of biopsies & FNAs) | ||
| Micro = | | Micro = | ||
| Subtypes = NSCC favour adenocarcinoma, NSCC favour squamous cell carcinoma, NSCC-not otherwise specified | | Subtypes = NSCC favour adenocarcinoma, NSCC favour squamous cell carcinoma, NSCC-not otherwise specified | ||
| LMDDx = [[lung adenocarcinoma]], [[squamous cell carcinoma of the lung|lung squamous carcinoma]], [[lung small cell carcinoma]], poorly differentiated metastatic [[carcinoma]] | | LMDDx = [[lung adenocarcinoma]], [[squamous cell carcinoma of the lung|lung squamous carcinoma]], [[lung small cell carcinoma]], poorly differentiated metastatic [[carcinoma]], other poorly differentiated neoplasms | ||
| Stains = | | Stains = | ||
| IHC = pankeratin +ve, [[CD56]] -ve, chromogranin A -ve, synaptophysin -ve, TTF-1 +ve/-ve, p63 +ve/-ve | | IHC = pankeratin +ve, [[CD56]] -ve, chromogranin A -ve, synaptophysin -ve, [[TTF-1]] +ve/-ve, [[p63]] +ve/-ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
Line 19: | Line 19: | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = no history of malignancy or no suspicion of recurrence | ||
| Signs = | | Signs = | ||
| Symptoms = | | Symptoms = +/-hemopytsis, +/-dyspnea | ||
| Prevalence = uncommon | | Prevalence = uncommon | ||
| Bloodwork = | | Bloodwork = | ||
Line 39: | Line 39: | ||
In the clinical context, it is often referred to as '''non-small cell lung cancer'''; this ignores the fact that not all non-small cell lung cancer fits into the [[carcinoma]] category. | In the clinical context, it is often referred to as '''non-small cell lung cancer'''; this ignores the fact that not all non-small cell lung cancer fits into the [[carcinoma]] category. | ||
''Poorly differentiated carcinoma of the lung'' and ''poorly differentiated lung carcinoma'' redirect to this article. | ''Poorly differentiated carcinoma of the lung'', ''non-small cell carcinoma'' and ''poorly differentiated lung carcinoma'' redirect to this article. | ||
==General== | ==General== | ||
Line 49: | Line 49: | ||
Clinical: | Clinical: | ||
*Radiologic findings should not be suggestive of a metastasis. | *Radiologic findings should not be suggestive of a metastasis. | ||
*No history of malignancy or no suspicion of recurrence. | |||
*+/-Hemopytsis. | |||
*+/-Dyspnea. | |||
==Microscopic== | ==Microscopic== | ||
Line 62: | Line 65: | ||
*Large cell variant of [[small cell carcinoma of the lung]]. | *Large cell variant of [[small cell carcinoma of the lung]]. | ||
*[[Lung metastasis]] - imaging suggestive of a metastasis or a history of malignancy. | *[[Lung metastasis]] - imaging suggestive of a metastasis or a history of malignancy. | ||
*[[Malignant melanoma]]. | |||
*Other poorly differentiated neoplasms | |||
===Grading=== | |||
*''NSCC-NOS'', ''NSCC favour adenocarcinoma'', ''NSCC favour SCC'' are grade 4. | |||
Note: | |||
*In a large series of patients, there is no statistical difference in survival been grade 3 and grade 4.<ref name=pmid16678584>{{Cite journal | last1 = Sun | first1 = Z. | last2 = Aubry | first2 = MC. | last3 = Deschamps | first3 = C. | last4 = Marks | first4 = RS. | last5 = Okuno | first5 = SH. | last6 = Williams | first6 = BA. | last7 = Sugimura | first7 = H. | last8 = Pankratz | first8 = VS. | last9 = Yang | first9 = P. | title = Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. | journal = J Thorac Cardiovasc Surg | volume = 131 | issue = 5 | pages = 1014-20 | month = May | year = 2006 | doi = 10.1016/j.jtcvs.2005.12.057 | PMID = 16678584 }}</ref> | |||
===Images=== | |||
<gallery> | |||
Image: Non-small cell lung carcinoma -- low mag.jpg | NSCLC - low mag. (WC) | |||
Image: Non-small cell lung carcinoma -- intermed mag.jpg | NSCLC - intermed mag. (WC) | |||
Image: Non-small cell lung carcinoma -- high mag.jpg | NSCLC - high mag. (WC) | |||
Image: Non-small cell lung carcinoma -- very high mag.jpg | NSCLC - very high mag. (WC) | |||
Image: Non-small cell lung carcinoma - alt -- very high mag.jpg | NSCLC - very high mag. (WC) | |||
</gallery> | |||
==IHC== | ==IHC== | ||
Line 69: | Line 89: | ||
Note: | Note: | ||
* | *If immunostains favour adenocarcinoma or squamous cell carcinoma, the case should be sign as ''favour adenocarcinoma'' or ''favour squamous cell carcinoma'', see ''Sloan-Kettering algorithm'' below and ''Sign out'' section. | ||
===Adenocarcinoma versus squamous carcinoma=== | ===Adenocarcinoma versus squamous carcinoma=== | ||
Line 102: | Line 122: | ||
|- | |- | ||
| Non-small cell carcinoma, favour adenocarcinoma | | Non-small cell carcinoma, favour adenocarcinoma | ||
| TTF-1 or napsin +ve | | [[TTF-1]] or napsin +ve | ||
|- | |- | ||
| Non-small cell carcinoma, favour squamous cell carcinoma | | Non-small cell carcinoma, favour squamous cell carcinoma | ||
| p40 or p63 +ve | | [[p40]] or [[p63]] +ve | ||
|- | |- | ||
| Non-small cell carcinoma-not otherwise specified | | Non-small cell carcinoma-not otherwise specified | ||
Line 111: | Line 131: | ||
|} | |} | ||
===Not otherwise specified=== | |||
<pre> | <pre> | ||
Lung, Left Lower Lobe, Core Biopsy: | Lung, Left Lower Lobe, Core Biopsy: | ||
Line 125: | Line 146: | ||
The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamous | The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamous | ||
markers (p63, CK5/6) are negative; thus, the tumour is not further classified. | markers (p63, CK5/6) are negative; thus, the tumour is not further classified. | ||
</pre> | |||
===Favour squamous=== | |||
<pre> | |||
Lung, Left Upper Lobe, Core Biopsy: | |||
- NON-SMALL CELL CARCINOMA, favour squamous cell carcinoma, see comment. | |||
Comment: | |||
The tumour stains as follows: | |||
POSITIVE: AE1/AE3, CK5/6, CK7. | |||
NEGATIVE: TTF-1, napsin A, p63, CDX2, CK20, S-100. | |||
EGFR/ALK testing has been ordered. | |||
The immunostains favour squamous cell carcinoma. | |||
</pre> | </pre> | ||
edits